Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,086.00
Bid: 3,090.00
Ask: 3,092.00
Change: 32.00 (1.05%)
Spread: 2.00 (0.065%)
Open: 3,054.00
High: 3,092.00
Low: 3,054.00
Prev. Close: 3,054.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

20 Dec 2022 07:00

RNS Number : 2386K
Bunzl PLC
20 December 2022
 

20 December 2022

 

BUNZL ANNOUNCEMENT REGARDING ACQUISITIONS AND DISPOSAL

 

Bunzl plc, the specialist international distribution and services Group, today announces that it has signed agreements to acquire four businesses and agreed to the sale of its UK healthcare division. Together, these transactions are expected to be profit neutral to the Group and will generate a small cash inflow. They reflect Bunzl's ongoing discipline around returns focused capital allocation and portfolio optimisation.

 

The Group has agreed to the sale of its UK healthcare division to Mediq. In 2021, the UK healthcare division generated £216 million of revenue.

 

The Group remains focused on expanding its specialist healthcare business and in November completed the acquisition of Toomac Ophthalmic & Solutions, a distributor of ophthalmology products in New Zealand. In the 12 months to March 2022 the business generated revenue of NZD 11 million (c.£6 million). In October, Bunzl also signed an agreement to acquire GRC, an exclusive distributor of innovative medical technology devices in Australia with revenue of AUD 4 million (c.£3 million) in the 12 months to June 2022. Both businesses specialise in surgical products and broaden the offering in Bunzl's healthcare business in the region, which has expanded significantly over the last two years.

 

In October, Bunzl also completed the acquisition of VM Footwear, a distributor of Personal Protection Equipment based in Czech Republic, specialising in own brand footwear throughout Central Eastern Europe and providing an entry into this category in the region. In the year to June 2022 the business generated CZK 366 million (c.£13 million) of revenue.

 

Furthermore, in November Bunzl completed the acquisition of PM Pack, a distributor of packaging products in Denmark, mainly focused on food processor customers. The acquisition strengthens the Group's foodservice offering in Denmark and in the year to September 2022 the business generated revenue of DKK 142 million (c.£16 million). 

 

Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"Today's announcement reflects Bunzl's commitment to optimal capital allocation across the Group. The announced acquisitions are highly complementary, expand our product offering in each country, and all achieve double digit margins, with their profits offsetting the expected profit contribution from the announced disposal. I would like to offer a warm welcome to all the teams from the newly acquired businesses to the Bunzl family.

 

I want to thank our departing colleagues for all the contributions they made as part of Bunzl, particularly most recently for their incredible dedication to supporting customers during the pandemic. I wish the whole team the very best for the future."

 

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

Tulchan

Martin Robinson

Olivia Peters

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQTLBLTMTABBTT
Date   Source Headline
2nd May 20242:00 pmRNSDirector/PDMR Shareholding
2nd May 20248:00 amRNSAdditional Listing
1st May 20245:00 pmRNSDirector/PDMR Shareholding
1st May 202410:00 amRNSBlock listing Interim Review
1st May 20249:18 amRNSTotal Voting Rights
25th Apr 20244:45 pmRNSDirector/PDMR Shareholding
24th Apr 20242:51 pmRNSResult of AGM
24th Apr 20247:00 amRNSTrading Statement
22nd Apr 20244:36 pmRNSDirector/PDMR Shareholding
18th Apr 20248:00 amRNSAdditional Listing
11th Apr 20248:00 amRNSAdditional Listing
3rd Apr 20245:28 pmRNSDirector/PDMR Shareholding
3rd Apr 20249:09 amRNSDirector/PDMR Shareholding
2nd Apr 20241:50 pmRNSTotal Voting Rights
21st Mar 20248:00 amRNSAdditional Listing
15th Mar 20243:28 pmRNSAnnual Financial Report
7th Mar 20248:00 amRNSAdditional Listing
5th Mar 20245:05 pmRNSDirector/PDMR Shareholding
4th Mar 20243:03 pmRNSDirector/PDMR Shareholding
1st Mar 202411:35 amRNSTotal Voting Rights
28th Feb 20243:17 pmRNSDirector/PDMR Shareholding
27th Feb 20245:26 pmRNSDirector/PDMR Shareholding
26th Feb 202410:30 amRNSDividend Declaration
26th Feb 20247:00 amRNSFinal Results
26th Feb 20247:00 amRNSAcquisition
5th Feb 20242:20 pmRNSDirector/PDMR Shareholding
1st Feb 20245:08 pmRNSTotal Voting Rights
12th Jan 20244:54 pmRNSDirector/PDMR Shareholding
11th Jan 20243:50 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:57 amRNSTotal Voting Rights
15th Dec 20235:10 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSTrading Statement
8th Dec 20235:32 pmRNSDirector/PDMR Shareholding
1st Dec 202311:32 amRNSTotal Voting Rights
20th Nov 20236:30 pmRNSPublication of Admission Particulars
3rd Nov 20239:30 amRNSDirector Declaration
2nd Nov 20232:29 pmRNSDirector/PDMR Shareholding
1st Nov 202311:24 amRNSTotal Voting Rights
1st Nov 20239:00 amRNSBlock listing Interim Review
24th Oct 20237:00 amRNSTrading Statement
6th Oct 20235:08 pmRNSDirector/PDMR Shareholding
4th Oct 20231:40 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:34 pmRNSTotal Voting Rights
2nd Oct 20231:33 pmRNSDirector/PDMR Shareholding
26th Sep 20232:10 pmRNSDirector/PDMR Shareholding
1st Sep 20232:30 pmRNSTotal Voting Rights
31st Aug 202310:30 amRNSDirector/PDMR Shareholding
29th Aug 202310:00 amRNSDividend Declaration
29th Aug 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.